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Abstract
Objectives To examine the effect of walking and vitamin
B supplementation on quality-of-life (QoL) in community-
dwelling adults with mild cognitive impairment.
Methods One year, double-blind, placebo-controlled trial.
Participants were randomized to: (1) twice-weekly, group-
based, moderate-intensity walking program (n = 77) or a
light-intensity placebo activity program (n = 75); and (2)
daily vitamin B pills containing 5 mg folic acid, 0.4 mg
B12, 50 mg B6 (n = 78) or placebo pills (n = 74). QoL
was measured at baseline, after six and 12 months using
the population-speciﬁc Dementia Quality-of-Life (D-QoL)
to assess overall QoL and the generic Short-Form 12
mental and physical component scales (SF12-MCS and
SF12-PCS) to assess health-related QoL.
Results Baseline levels of QoL were relatively high.
Modiﬁed intention-to-treat analyses revealed no positive
main intervention effect of walking or vitamin supple-
mentation. In both men and women, ratings of D-QoL-
belonging and D-QoL-positive affect subscales improved
with 0.003 (P = 0.04) and 0.002 points (P = 0.06) with
each percent increase in attendance to the walking pro-
gram. Only in men, SF12-MCS increased with 0.03 points
with each percent increase in attendance (P = 0.08).
Conclusion Several small but signiﬁcant improvements
in QoL were observed with increasing attendance to the
walking program. No effect of vitamin B supplementation
was observed.
Trial Registration International Standard Randomized
Controlled Trial Number Register, 19227688, http://
www.controlled-trials.com/isrctn/.
Keywords Quality of life  Aged  Exercise  Dietary
supplements  Randomized controlled trial
Abbreviations
ADL activities of daily living
D-QoL dementia quality of life
FA/B12/B6 folic acid, vitamin B12, vitamin B6
MCI mild cognitive impairment
PAP placebo activity program
QoL quality of life
SF-12 short form 12
SF12-MCS SF-12 mental component summary
SF12-PCS SF-12 physical component summary
WP walking program
Introduction
Especially in older people, both mental and physical
function decrease due to multiple age related changes,
which in turn may affect quality of life (QoL). The most
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which is a common aspect of aging. However, in some
cases decline is more serious than expected for a certain
age. This is speciﬁed as Mild Cognitive Impairment (MCI).
MCI is considered to be a potential transitional stage be-
tween normal cognitive function and Alzheimer’s disease,
characterized by (1) subjective memory complaint (2)
objective memory impairment (3) normal mental status (4)
intact activities of daily living (ADL) (5) absence of
dementia [1]. Independent of the latter four criteria, sub-
jective memory complaints are related to lower QoL [2].
Moreover, MCI is associated with poor physical health and
high risk of ADL dependence [3, 4]. Since both cognitive
and physical decline belong to the most important deter-
minants of QoL in community dwelling elderly subjects
[5], subjects with MCI are likely to be susceptible to a
decrease in QoL.
The number of adults with MCI is increasing consider-
ably due to the aging population. For multiple reasons, it is
important to prevent a decrease in QoL. Apart from the
personal beneﬁts, a high rated QoL also reduces medical
consumption and helps to maintain independency as long
as possible [6]. This in turn may relieve signiﬁcant others,
caregivers and medical society in general. For this reason,
attention should be paid to possible interventions contrib-
uting towards a higher level of overall QoL and it’s mental
and physical components. In this respect, physical exercise
and vitamin supplementation are interesting interventions
worth investigating. Regular participation in moderate
intensity aerobic training is reported to be beneﬁcial in
improving QoL and wellbeing, which is an important as-
pect of QoL [7, 8]. Since walking is the most prevalent
physical activity among older adults [9], improving QoL by
increasing the time spent on moderate intensity walking
seems promising. Indeed, a community based walking
program signiﬁcantly improved both the physical and
mental components of health-related QoL in older adults
(n = 582) [10]. Inconclusive evidence has been reported
on the inﬂuence of vitamin B supplementation on QoL.
Different aspects of QoL were not responsive to short
term supplementation (range 4–12 weeks) with different
doses and combinations of B vitamins in men and women
[11–13].
Not much is known about QoL in community dwelling
elderly with MCI. Moreover, no trials on the effect of
exercise and vitamin B supplementation on QoL have been
carried out yet in adults with MCI. The FACT-study (Fo-
late physical Activity Cognition Trial) was developed to
examine the effect of these interventions on cognition [14].
Aspects of QoL were measured as a secondary outcome. In
the present paper, the effectiveness of 1 year moderate
intensity walking (two sessions of 60 min per week) and
daily vitamin supplementation (5 mg folate, 50 mg vitamin
B6 and 0.4 mg B12) on both overall QoL and it’s health-
related components is examined in community dwelling
older adults with MCI. We hypothesize that 1 year mod-
erate intensity walking beneﬁts QoL. Concerning the effect
of vitamin supplementation, this paper should be consid-
ered as explorative.
Methods
Study design
The study was designed as a randomized, placebo con-
trolled intervention trial, based on a two-by-two factorial
design. The study-protocol has been described in detail
elsewhere [14] and was approved by the VU University
Medical Center medical ethics committee. Written in-
formed consent was obtained from all participants.
Participants
In a medium-sized Dutch town community dwelling sub-
jects aged 70–80 years with MCI were identiﬁed using a
population based two-step-screening [15]. The operational
criteria for MCI according to the criteria of Petersen et al.
[1] and additional inclusion criteria for the RCT are de-
scribed in Table 1. Subjects were not paid to participate in
the study.
Randomization
After the baseline interview, subjects were randomly as-
signed to the interventions using the statistical computer
program SPSS. Intervention groups were: (1) walking
program or placebo activity program; and (2) vitamin B
supplementation or placebo supplementation. Randomiza-
tion was stratiﬁed for physical activity level at baseline in
minutes per day as measured by the LASA physical
activity questionnaire [22]. For the ﬂow of participants see
Fig. 1.
Exercise intervention
Subjects assigned to the walking program (WP) partici-
pated twice a week 60 min in group-based moderate
intensity walking during 1 year. Each session consisted of
a warming up, moderate intensity walking exercises and a
cooling down. The WP was based on ‘Sportive Walking,’
an existing aerobic walking program [23] aimed at
improving cardiovascular endurance. Therefore, duration
and intensity of the walking exercises increased gradually
during the program. Sessions took place outdoor in muni-
cipal parks. Subjects not assigned to the WP participated in
1138 Qual Life Res (2007) 16:1137–1146
123Table 1 Inclusion and exclusion criteria for participation in the trial
Operationalization of Petersen criteria for MCI (1–5) and additional inclusion criteria for the RCT (6–12)
1. Memory complaints (answer yes to question ‘do you have memory complaints’, or at least twice sometimes at cognition scale of Strawbridge
[16]
2. Objective memory impairment; 10 WLT delayed recall £ 5 + percentage savings £ 100 [17]
3. Normal general cognitive functioning; TICS ‡ 19 + MMSE ‡ 24 [18, 19]
4. Intact daily functioning: no report of disability in activities of daily living on GARS-scale, except on the item ‘taking care of feet and toe nails’
[20]
5. Absence of dementia; TICS ‡ 19 + MMSE ‡ 24
6. Being able to perform moderate intensity physical activity, without making use of walking devices, e.g., a rollator or a walking frame
7. Not using vitamin supplements/vitamin injections/drinks with dose of vitamin B6, B11 or B12 comparable to vitamin supplement given in
intervention
8. Not suffering from epilepsy, multiple sclerosis, Parkinson’s disease, kidney disorder requiring haemodialysis, psychiatric impairment
9. Not suffering from depression as measured by the GDS (cut off £ 5) [21]
10. Not using medication for rheumatoid arthritis or psoriasis interfering with vitamin supplement
11. No alcohol abuse (men < 21 consumptions a week, women < 15 consumptions a week)
12. Not currently living in a nursing home or on a waiting list for a nursing home
MCI = Mild Cognitive Impairment, RCT = Randomized Controlled Trial, 10 WLT = 10 Word Learning Test, TICS = Telephone Interview for
Cognitive Status, MMSE = Mini Mental State Examination, GARS = Groningen Activity Restriction Scale, GDS = Geriatric Depression Scale
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Fig. 1 Flow chart.
TI = Telephone Interview,
WP = Walking Program,
PAP = Placebo Activity
Program, FA/B12/B6 = Folic
Acid, Vitamin B12, Vitamin
B6 supplementation,
SO = signiﬁcant other,
T6 = follow-up after 6 months,
T12= follow-up after
12 months, *reason for
exclusion: only baseline data
available
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123a placebo activity program (PAP) with the same frequency,
session duration and program duration. However, the PAP
consisted of low intensity exercise, such as light range of
motion movements and stretching. Sessions were divided
into ﬁve themes: relaxation, activities of daily living, bal-
ance, ﬂexibility, posture and a combination of all. For each
theme three sessions were developed and the entire series
of 18 sessions was repeated during the intervention period.
The PAP was carried out in community centers. Both
programs were supervised by qualiﬁed and trained
instructors. Attendance to both programs was assessed by
the percentage of attended sessions.
Vitamin supplementation (FA/B12/B6)
Subjects in the vitamin supplementation group took one
pill containing 5 mg vitamin B11 (Folic Acid), 0.4 mg
vitamin B12 (Cyanocobalamin) and 50 mg vitamin B6
(Pyridoxine-hydrochloride) daily during 1 year. This vita-
min supplement is available on prescription in The Neth-
erlands. Subjects randomized to the control group took an
identically looking placebo pill. The pills were packed in
blister packs for 1 week, which were labeled for each day
of the week. Compliance with the vitamin supplementation
was veriﬁed by pill counts in returned blister packs during
the intervention.
Outcome measures
Baseline data on sociodemographic and background vari-
ables were collected using a postal screening questionnaire.
The measurement of other baseline variables, as reported in
Table 2, has been described elsewhere [14]. In the present
manuscript a distinction was made between ‘overall quality
of life,’ referring to a subjects overall enjoyment of life and
‘health-related quality of life,’ referring to health-related
factors affecting quality of life. The term QoL was used as
an umbrella term for both overall and health-related QoL.
The population-speciﬁc Dementia Quality of Life ques-
tionnaire (D-QoL) [24] was used to assess overall QoL and
the generic Short Form 12 (SF12) [25] to assess health-
related QoL. The D-QoL is a 29 item measure especially
developed for elderly with cognitive decline and dementia.
The participant is asked about how much they enjoyed
activities that were reported to be important for elderly
such as ‘watching animals.’ Moreover, the frequency of
certain positive and negative feelings such as ‘lovable’ or
‘worried’ were asked for. Finally, they were asked to rate
their overall quality of life. The participant was instructed
to choose the best ﬁtting answer from ﬁve item response
scales. The answers were divided into ﬁve domains of QoL
measuring sense of aesthetics, feelings of belonging, neg-
ative affect, positive affect/humor and self esteem. A mean
score ranging from one to ﬁve was calculated for these
subscales and for the total D-QoL. A higher score indicated
better quality of life. Median internal consistency reliabil-
ity of the D-QoL was 0.80 and median test–retest reliability
was 0.72 in a sample of 95 older adults with different
stages of cognitive decline [24]. The SF12 consists of 12
items measuring eight concepts of both mental and physi-
cal health, i.e., physical functioning, role-physical, bodily
pain, general health, energy, social functioning, role emo-
tional and mental health. These concepts are subdivided
into two summary scores using a norm-based criterion: i.e.,
mental and physical component summary scales (SF12-
MCS and SF12-PCS). The mean score is 50 with a standard
deviation of 10. For example, a score of 60 corresponds to
a-QoL rating of one standard deviation above the average
ratings in the general population. Test retest reliability for
the SF-12 MCS was 0.76 in a sample of 187 adults in the
United Kingdom and 0.77 in a sample of 232 adults in the
United States. Reliability coefﬁcients of the SF-12 PCS in
these populations were 0.86 and 0.89, respectively [25]. In
the present study, measurement took place during a per-
sonal interview at baseline and after 6 and 12 months. Both
the D-QoL and the SF-12 were administered by a trained
interviewer who was unaware of the participants’ group
allocation.
Statistical analyses
Differences between groups on baseline characteristics
were tested using independent t-tests (normally distributed
variables), Mann–Whitney U tests (not normally distrib-
uted variables) and v
2 (categorical variables). Within group
differences were tested using dependent t-tests.
Subsequently, data were analyzed according to a mod-
iﬁed intention-to-treat principle, based on data from all
randomized participants who provided data at baseline and
at least one follow-up measurement. To evaluate the effects
of the walking program and the vitamin supplementation
on QoL, longitudinal regression analysis was used. The two
follow-up measurements were deﬁned as dependent vari-
able and multi level analysis with two levels was used, (1)
time of follow-up measurement (values corresponding with
performance after six and 12 months intervention); (2)
individual. According to the study protocol [14], the effect
of both interventions was examined independently from
each other. Data were analyzed using a crude and an ad-
justed model. Independent variables were exercise inter-
vention and vitamin intervention. By analyzing both
interventions in the same model, results were adjusted for
the possible inﬂuence of the other intervention. Moreover,
all analyses were adjusted for baseline performance on the
outcome measure by adding this as a covariate. In the
adjusted model, education, baseline activity level, baseline
1140 Qual Life Res (2007) 16:1137–1146
123vitamin status, attendance to the exercise program and
compliance with the supplementation were added as co-
variates. Interaction between gender and the WP or FA/B6/
B12-supplementation was checked in the adjusted model.
In the case of signiﬁcant interaction, results were reported
for men and women separately. In the case of no interac-
tion, gender was added to the adjusted model as an addi-
tional covariate. Also, in the ‘adjusted model’ an
interaction effect of the exercise program with attendance
to the exercise program was checked. Finally, data were
analyzed according to the per protocol principle, including
all participants who attended at least 75% of the sessions.
This cut-off point is in concordance with previous exercise
intervention studies in older adults [26, 27].
Data were analyzed using SPSS for Windows (release
12.0.1). A signiﬁcance level of 5% was used for between
group comparisons and of 10% for interaction terms. For
all analyses, regression coefﬁcients and 95% conﬁdence
intervals for the adjusted models were reported, with the
regression coefﬁcients directly indicating the difference in
QoL ratings between the WP and the PAP or the FA/B12/
B6-supplementation versus placebo supplementation. In
the case of signiﬁcant interaction, regression coefﬁcients
and the 95% conﬁdence intervals of the interaction terms
were reported.
Results
Patient characteristics
Hundred-seventy-nine participants were randomized to the
interventions. Twenty-seven of them were excluded from
the analyses, because they only provided baseline data.
These subjects were more often married (71% vs. 52%,
P = 0.05) and less often current smokers (0% vs. 14%,
P = 0.04) than the remaining 152 participants who pro-
vided QoL data at baseline and at at least one follow-up
measurement. The latter 152 participants were included in
the analyses (see Fig. 1). Their mean age (SD) was 75
(2.9) years. Fifty-six percent was male. Additional base-
line variables are described per factor in Table 2. Com-
pared to the PAP, the WP included fewer men (48% in
WP vs. 64% in PAP) and more subjects with hypertension
(27% in WP vs. 14% in PAP). Ratings for both overall
and health-related QoL at baseline and after 6 and
12 months intervention are presented in Table 3.N o
baseline differences were observed on these measures,
except for a higher rating of D-QoL self-esteem in sub-
jects in the FA/B12/B6-group compared to subjects in the
placebo-supplementation group.
Table 2 Baseline characteristics of participants (n = 152)
Exercise intervention Vitamin intervention
WP (n = 77) PAP (n = 75) FA/B12/B6 (n = 78) Placebo-pill (n = 74)
Age (Mean (SD)) 75 (2.9) 75 (2.8) 75 (2.8) 75 (2.9)
Gender (% male) 48* 64 56 55
MMSE (Median (10th–90th &)) 29 (26–30) 29 (27–30) 29 (25–30) 29 (27–30)
Education (% low/middle/high) 61/22/17 52/29/19 57/26/17 55/26/19
Marital status (% living together) 75 68 69 73
Physical activity
a (min/day) (Median (10th–90
th &)) 44 (10–155) 39 (11–120) 45 (13–155) 38 (9–111)
Vitamin status (% deﬁcient FA/B12/B6)
b 46/8/0 48/8/0 49/9/0 45/7/0
Homocysteine status
c (% hyperhomocysteinemia) 27 23 27 23
Blood pressure (% hypertension)
d 27* 14 25 16
BMI (kg/m
2) (Median (10th–90th p&)) 26.7 (23.1–31.5) 26.6 (23.5–32.7) 26.5 (23.3–32.8) 26.7 (23.5–31.2)
Smoking (% smokers) 13 15 17 11
Number of self-reported diseases (% 0,1,2)
e 52/42/6 69/27/4 66/28/6 55/41/4
WP = Walking Program, PAP = Placebo Activity Program, FA/B12/B6 = Folic Acid, Vitamin B12, Vitamin B6 supplementation,
MMSE = Mini Mental State Examination, Education: low = no education, primary education, lower vocational training; intermedi-
ate = intermediate level secondary education, intermediate vocational training; high = higher level secondary education, higher vocational
training, university training. BMI = Body Mass Index
a ‡3.0 metabolic equivalents
b Cut off points: FA red blood cell <337 nmol/l or FA plasma < 6,3 nmol/l; B12 £ 150 pmol/l; B6 < 20 nmol/l
c Homocysteine > 14 mmol/l
d Hypertension = diastole ‡ 90 and systole ‡160
e Cardiovascular disease, chronic obstructive pulmonary disease, diabetes, epilepsy, multiple sclerosis, Parkinson’s disease, psychiatric disease,
renal failure requiring dialysis and/or rheumatoid arthritis
* Signiﬁcantly different from PAP (P < 0.05)
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123Attendance to the WP and the PAP
Overall median attendance to the exercise programs (10th–
90th percentile) was 63 (0–89) percent and did not differ
between the WP and the PAP. Especially in the ﬁrst weeks,
a considerable number of subjects discontinued participa-
tion, mostly because they did not want to participate in the
exercise programs after all. Most frequent reasons for
discontinuation of the program after the ﬁrst weeks were
health-related problems. No adverse events of the WP or
PAP itself were reported. Adherent subjects attending at
least 75% of the sessions (n = 51) were more often living
together (82% vs. 65%, P = 0.03) and less physically ac-
tive than non-adherers (n = 101), (median [10th–90th
percentile] was 36 [13–82] vs. 44 [10–169] min/day,
P = 0.02). At baseline, adherers also had lower ratings of
D-QoL-belonging (3.6 [0.41] vs. 3.8 [0.49], P = 0.02) and
higher SF12-MCS values (56.5 [5.6] vs. 53.7 [8.1],
P = 0.02). Other baseline and QoL characteristics did not
differ signiﬁcantly.
Compliance with the (FA/B12/B6)supplementation
Four participants did not return the blister packs. On the
basis of pill counts in returned blister packs, median
compliance (10th–90th percentile) with the FA/B12/B6-
supplementation was 100 (97–100) percent and compliance
with placebo-supplementation was 100 (35–100) percent.
Even though median compliance in both groups was 100%,
compliance in the placebo-group was signiﬁcantly lower
(P < 0.05). Eight subjects, one in the FA/B12/B6-group
and seven in the placebo-group, did not take (vita-
min)supplementation. Seven of them decided immediately
after randomization not to participate in the interventions.
The other wanted to participate in the exercise intervention
only. Two participants discontinued taking vitamin pills
during the trial after reporting sleep problems and in-
creased forgetfulness; one participant discontinued taking
the placebo pills after reporting not feeling well.
Modiﬁed intention to treat analyses
Results of the walking program and FA/B6/B12 supple-
mentation are presented in Table 4. With respect to overall
QoL, no positive signiﬁcant main effect of the WP or FA/
B6/B12 supplementation was found. A signiﬁcantly detri-
mental effect of FA/B6/B12 supplementation was observed
on D-QoL-belonging, (beta (95%CI) = –0.18 (–0.29; –
0.07), P < 0.01). A positive interaction between the WP
and attendance to the WP was observed on D-QoL-
belonging and D-QoL-positive affect. With each percent
increase in attendance, D-QoL-belonging increased with
0.003 points (P = 0.04) and D-QoL-positive affect with
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1230.002 points (P = 0.06) in the WP compared to the PAP.
With respect to health-related QoL, an interaction between
the WP and gender was observed on the SF12-MCS
(P = 0.06) and therefore analysis for the SF12-MCS was
stratiﬁed for gender. No main effects of the WP or FA/B12/
B6-pills were observed. However, in men in the WP, SF12-
MCS increased with 0.03 points with each percent increase
in attendance (P = 0.08).
Per protocol analyses
Subgroup analyses were performed in subjects attending
75% or more of the WP or PAP sessions (n = 51, 33 men
and 18 women). No between group differences were ob-
served for FA/B12/B6-pills versus placebo-pills. A signif-
icant positive effect of the WP compared to the PAP was
observed on D-QoL-positive affect, beta (95%CI) = 0.23
(0.06; 0.39), P < 0.01 and a borderline signiﬁcant positive
effect on D-QoL-self esteem, beta (95%CI) = 0.17 (0.001;
0.34), P = 0.05.
Discussion
No positive main effect of walking or daily FA/B6/B12
supplementation was observed on QoL in community-
dwelling adults with MCI. However, ratings of overall QoL
(i.e., feelings of belonging, positive affect) and the mental
component of health-related QoL improved slightly with
increasing attendance to the walking program. In a sub-
group that attended at least 75% of the sessions, a beneﬁ-
cial effect of the walking program was observed on
positive affect and self esteem.
To our knowledge, this is the ﬁrst intervention study on
QoL in community-dwelling adults with MCI. While
memory complaints are reported to be negatively associ-
ated with QoL in healthy older adults with subjective
memory complaints [2], QoL ratings in our study popula-
tion were already quite high at baseline. Baseline ratings on
the DQOL sumscore and subscales fell ample above the
midpoint of the scale, except for negative affect. Baseline
scores on the SF-12MCS fell around a half standard
deviation above the average in the general population and
SF-12PCS fell about the average ratings. QoL-ratings have
been reported to decrease as the severity of cognitive de-
cline increases [28]. The possibility exists that MCI as
operationalized in the present study may not have been
serious enough to negatively inﬂuence overall and health-
related QoL. In spite of the high baseline values, the QoL
scales still allowed for further improvements, i.e., there
was no ceiling effect. However, it has been discussed be-
fore that QoL may represent a stable concept, which is
difﬁcult to change or that existing measures may not be
responsive to subtle changes [29].
The relationship between physical activity and QoL
has been studied extensively. However, it is difﬁcult to
draw a clear conclusion, since various deﬁnitions and
operationalizations of QoL circulate. Moreover, compar-
isons between studies are being complicated by the wide
variety of study populations and features of exercise
intentions such as intensity, exercise mode, frequency
and session and total duration [30]. However, Rejeski
et al. [31] concluded in a review including 28 studies, of
which 11 RCT’s, that physical activity positively inﬂu-
enced aspects of health-related QoL. In a recent meta-
analysis of Netz et al. [7] including 36 studies, a small
Table 4 Results of longitudinal multi level analyses on the effect of the WP and FA/B6/B12 supplementation on change in QoL (adjusted
model)
WP versus PAP
Beta (95%CI)
P-value FA/B12/B6 versus placebo
Beta (95%CI)
P-value
D-QoL sumscore 0.04 (–0.03;0.10) 0.25 –0.06 (–0.12;0.004) 0.07
D-QoL aesthetics 0.06 (–0.07;0.20) 0.37 –0.07 (–0.20;0.07) 0.33
D-QoL belonging 0.00 (–0.11;0.11) 0.96 –0.18 (–0.29; –0.07) 0.00
D-QoL negative affect –0.02 (–0.12;0.08) 0.65 0.04 (–0.05;0.14) 0.37
D-QoL positive affect 0.04 (–0.04;0.13) 0.34 –0.04 (–0.12;0.04) 0.33
D-QoL self esteem 0.08 (–0.02;0.18) 0.11 0.00 (–0.10;0.11) 0.94
SF12-PCS 0.66 (–1.23;2.54) 0.49 –0.73 (–2.65;1.19) 0.45
SF12-MCS* Men –0.82 (–2.24;0.60) 0.25 0.25 (–1.31;1.81) 0.76
Women 1.66 (–1.50;4.81) 0.30 1.32 (–1.93;4.56) 0.42
WP = Walking Program, PAP = Placebo Activity Program, FA/B12/B6= Folic Acid, Vitamin B12, Vitamin B6 supplementation, D-
QoL = Dementia Quality of Life, SF12-MCS = Short Form 12 Mental Component Summary, SF12-PCS = Short Form 12 Physical Component
Summary
* Interaction WP and gender
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123positive effect of exercise was observed on wellbeing in
healthy older adults. In that meta-analysis four compo-
nents of wellbeing were considered, including aspects
that were also measured in the FACT-study, such as
positive and negative affect, perception of physical ﬁtness
and physical symptoms.
In the present study no main effects of the WP were
observed in the modiﬁed intention to treat analyses. First, a
possible explanation for the lack of effect may be that only
participants with good QoL were able to attend enough
sessions. In contrast to an earlier study, no baseline dif-
ferences in number of chronic diseases, physical health-
related QoL and endurance were observed between adh-
erers (attending ‡75% of the sessions) and non-adherers
(attending <75% of the sessions) [32]. However, adherers
rated their mental health-related QoL at baseline signiﬁ-
cantly better than non-adherers. The difference was three
points, which approximately equaled a difference of 5%.
The possibility exists that subjects with lower mental
health-related QoL were inclined to attend less sessions.
Nevertheless, it is not likely that this biased our results,
because non-adherers and drop-outs from the exercise
programs were included in the modiﬁed intention to treat
analyses. In future studies in subjects with cognitive de-
cline, session attendance may be improved by informing
subjects extensively about the study aims and the conse-
quences of participation. Moreover, if possible with respect
to logistic and ﬁnancial issues, we advice to schedule time
and staff for the close personal follow-up of temporary
drop-outs.
Second, it has been reported that the association be-
tween physical activity and QoL is lower among older
adults who function at or above the norm [31]. By applying
inclusion criteria for the present trial (e.g., community
dwelling, no ADL disabilities, being able to perform
moderate intensity physical activity), we presumably se-
lected physically healthy and active subjects. This is sup-
ported by the high baseline activity levels. Two-thirds of
the participants reported to be physically active at moderate
intensity for 30 min or more per day. Subjects meeting this
guideline are reported to have better health-related QoL
than physically inactive adults [8]. Additionally, Netz et al.
found that larger effects of exercise on wellbeing were
observed in sedentary adults [7]. However, in the present
study, no interaction between the walking program and
baseline physical activity level was observed (results not
presented), indicating that inactive participants did not
beneﬁt more from the WP than active participants.
Therefore, it is not likely that baseline physical activity
level was a main cause of the lack of main effects.
Finally, inconclusive evidence is available about the
intensity and exercise mode of physical activity required
to beneﬁt QoL. Netz et al. [7] concluded that aerobic
training of moderate intensity was most beneﬁcial for
wellbeing. In a cross-sectional study, it was also observed
that moderate intensity physical activity was positively
related to health-related QoL [8]. In contrast, in a review
by Spirduso and Cronin [33] no evidence of a relation-
ship between exercise intensity and the rate of
improvement in QoL was found. If the former would be
true, the possibility exists that the contrast between both
programs in the present study would not have been large
enough to induce differences in QoL. If the latter would
be true, participants would have beneﬁted from partici-
pation in both exercise programs regardless of intensity.
Both programs may either have added to better self-
efﬁcacy, or may prevented a decline in self-efﬁcacy. The
walking program by training cardiovascular endurance;
the placebo activity program by training e.g., balance and
ADL. Self-efﬁcacy refers to somebody’s belief that one
has the capabilities to successfully manage situational
demands and is mentioned to be a mediating mechanism
for the effect of physical activity on QoL [7, 30, 34, 35].
Thus, the presence of the low intensity placebo activity
program in our study may have contributed towards the
lack of between group differences.
Nevertheless, several outcomes improved with increas-
ing attendance to the walking program. In the per protocol
analyses a beneﬁcial effect was observed on positive affect.
Self esteem also tended to improve. However, observed
differences were small and approximated 5% differences
from baseline QoL ratings. As a rule of thumb, a minimal
change of 5% has been mentioned to signify clinical rele-
vance. To obtain a change of 5% by increasing attendance,
the required increase in attendance would be 62% for D-
QoL-belonging and 94% for D-QoL-positive affect and the
SF12-MCS. Therefore, it can be questioned whether the
observed effects are clinically relevant.
No effect of the FA/B12/B6 supplementation was ob-
served except for a negative effect on feelings of belong-
ing. However, no theoretical rationale exists for this effect.
Our ﬁndings are in line with previous RCT’s on the effect
of vitamin B supplementation on aspects of QoL. Deijen
et al. [11] observed no effect of supplementation with
20 mg vitamin B6 for 3 months on mood in healthy men
(n = 76). Also no effect of supplementation with 750 lg
folate, 15 lg vitamin B12 or 75 mg vitamin B6 daily for
35 days was observed on mood in women aged 65 or over
(n = 75) [11]. Finally, no effect on health-related QoL was
observed of a weekly injection with 1 mg vitamin B12 for
4 weeks in adults with vitamin B12 deﬁciency (n = 140)
[13]. These ﬁndings may ﬁnd its origin in the used oper-
ationalizations and measures of QoL that include very few
items that directly relate to nutrition. Amarantos et al. [36]
underline the need to develop QoL measures including
items that relate nutrition to QoL.
1144 Qual Life Res (2007) 16:1137–1146
123To conclude, the walking program and vitamin B sup-
plementation were not effective in improving QoL in
community-dwelling older adults with MCI within 1 year.
However, increasing attendance to moderate intensity
physical activity may beneﬁt certain aspects of QoL.
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